bpc-157 human clinical trial evidence safety fda status Repost @peptides with @use.repost ・・・ BREAKING NEWS! Today's 8–6 advisory vote for is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents FDA's Overreach on Compounded Peptides

FDA's Overreach on Compounded Peptides FDA Discusses Peptide Bulk Substances BPC 157 and More Hillary Lin, MD posted on the topic LinkedIn An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with 83% of peptide aware Americans want the FDA to make peptides more accessible AOL

SKU: 13686217966 · From composequickly.com